Crowley v Zurich Assurance plc & Ors

Factual and Procedural Background

The appeal arises from the dismissal by the High Court of the Plaintiff's action concerning the refusal by Company A to pay a claim under a serious illness insurance policy. The Plaintiff, acting as a litigant in person, challenged the refusal of his claim following a medical procedure. The Defendants included Company A, its Chief Executive Officer, and a Claims Assessor involved in handling the claim. The Financial Services Ombudsman was initially a party but was discharged by the High Court. Company A sought to strike out the Plaintiff's action on grounds including res judicata, issue estoppel, and abuse of process. The High Court held that the Plaintiff's claim was barred by res judicata because he had pursued the claim before the Financial Services Ombudsman and failed to exercise his statutory right of appeal to the High Court within the prescribed time. The Plaintiff subsequently attempted unsuccessfully to have the High Court revisit the decision, alleging errors. The present appeal challenges the High Court's dismissal and includes a procedural motion alleging deceit and misconduct by the Defendants, which the Court of Appeal did not separately consider.

Legal Issues Presented

1. Whether the principle of res judicata bars the Plaintiff’s claim given the prior determination by the Financial Services Ombudsman and the Plaintiff’s failure to appeal within the statutory timeframe.
2. Whether there are any exceptional or special circumstances justifying departure from the application of res judicata.
3. Whether the medical evidence and interpretation of the insurance policy terms support the Plaintiff’s entitlement to benefits under the serious illness policy.
4. Whether the Plaintiff’s procedural motion alleging deceit and misconduct by the Defendants can be entertained alongside the appeal.

Arguments of the Parties

Appellant's Arguments

• The Plaintiff contended that the refusal of his claim was unfair and incorrect because the medical procedure he underwent met the policy’s criteria for payment.
• He alleged that the Defendants misrepresented the critical policy condition and engaged in misconduct and deceit in handling his claim and the proceedings.
• The Plaintiff argued that the cardiologist’s decision not to stent multiple arteries penalised him unfairly under the policy terms.
• He submitted extensive documentation and authorities to support his position and challenged the Defendants' interpretation of the policy wording.

Respondents' Arguments

• The Defendants argued that the Plaintiff’s claim was barred by res judicata because the Financial Services Ombudsman had made a final determination and the Plaintiff failed to appeal within the statutory period.
• They maintained that the medical evidence confirmed the Plaintiff’s procedure treated only one coronary artery, not two or more as required by the policy.
• The Defendants submitted that no exceptional circumstances existed to justify setting aside res judicata, and that any allegations of fraud or misconduct were not pleaded or substantiated.
• They also contended that the inclusion of the CEO and Claims Assessor as defendants was unjustified since the complaint was against the insurer.

Table of Precedents Cited

Court's Reasoning and Analysis

The Court of Appeal undertook a detailed review of the factual and medical evidence relating to the Plaintiff’s insurance claim. The central issue was whether the medical procedure—angioplasty and stenting—met the policy requirement of treating narrowing in two or more coronary arteries. The medical evidence, including reports from multiple consultant cardiologists and the Plaintiff’s general practitioner, consistently indicated that only one coronary artery (the left anterior descending artery) was treated by stenting, while other narrowed arteries were managed medically without intervention.

The Court identified an error by the trial judge in misreading a report by the treating cardiologist, which led to an incorrect conclusion that a branch artery had also been stented. The Court clarified that the branch artery was not treated but left untreated by clinical decision. Nevertheless, this error did not affect the overall conclusion that the policy conditions were not met.

Regarding the procedural history, the Court emphasised the statutory framework governing the Financial Services Ombudsman’s jurisdiction and the right of appeal to the High Court. The Ombudsman’s decision was final and binding unless appealed within the prescribed 21-day period, which the Plaintiff did not do. The Court referred extensively to established case law confirming that an adverse determination by a statutory ombudsman constitutes res judicata and bars subsequent litigation on the same matter.

The Court noted that no special or exceptional circumstances existed to justify departing from the application of res judicata. The Plaintiff’s allegations of deceit and misconduct were not substantiated or pleaded with sufficient particularity, and there was no fraud alleged that could invoke the exceptional common law jurisdiction to set aside the prior judgment.

The Court also observed that the inclusion of the CEO and Claims Assessor as defendants was unwarranted since the complaint was directed at the insurer itself.

Holding and Implications

The Court of Appeal DISMISSED the Plaintiff’s appeal and associated procedural motion.

The direct effect of this decision is that the Plaintiff’s claim, having been conclusively determined by the Financial Services Ombudsman and not appealed within the statutory period, is barred by the doctrine of res judicata. No exceptional grounds exist to reopen or challenge this final determination. The ruling upholds the finality of statutory ombudsman decisions within their regulatory framework and reinforces the importance of adhering to procedural appeal rights. No new legal precedent was established beyond the application of existing principles to the facts of this case.